Fresh analysis suggests that individuals who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds much more quickly than those who stop conventional diet and exercise programs.
Findings released in a leading health publication shows that while overweight people often shed a large proportion of their total mass while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"People using these treatments need to be cognizant of the risk of quick weight regain when the medication is stopped," cautioned researcher Dr. Susan Jebb.
That rate of regain means a reversion to starting mass in about one and a half years.
Analyzing Approaches
The study, which examined 37 of trials involving thousands of participants, contrasted the outcomes of these new drugs with other pills.
Researchers emphasize that people who shed pounds through diet and exercise generally experience a more gradual creep back—around 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Nutrition scientists propose the mode of action of the injections is key to understanding the amplified rebound.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to produce less of its endogenous hormone, and could lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Disease?
The NHS advise the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of relapse, the therapy should be considered ongoing.
This opinion is reinforced by drug manufacturers, who note that the findings "emphasize the chronic nature of excess weight," similar to managing conditions like diabetes.
Patient Experiences
People who have come off the medication explain a sudden return of hunger.
"It was like a trigger activating and you become ravenous," described an individual.
The struggle is compounded if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Widespread Interest
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.
- Adoption is greater among females compared to men.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Finally, researchers caution that while the jabs are powerful agents for shedding pounds, they are not a permanent solution and long-term success likely depends on ongoing lifestyle changes.